𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum lipids concentration in women with benign and malignant ovarian tumours

✍ Scribed by Halina Gadomska; Barbara Grzechocińska; Jerzy Janecki; Grażyna Nowicka; Michał Powolny; Longin Marianowski


Book ID
116433829
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
180 KB
Volume
120
Category
Article
ISSN
0301-2115

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Serum CA 125 concentrations in patients
✍ Dr. Paul K. Buamah; Andrew W. Skillen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Serum CA 125 concentrations have been measured in 115 patients with histologically confirmed nonmalignant pelvic disease, that is, serous cystadenoma (n = 56), mucinous cystadenoma (n = 14), fibroma (n = 33), thecoma (n = 8), and Brenner tumour (n = 4). Increased CA 125 concentrations (>35 KU/L) wer

Expression of MUC1 splice variants in be
✍ Andreas Obermair; Bernd C. Schmid; Leisl M. Packer; Sepp Leodolter; Peter Birner 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 147 KB

## Abstract MUC1 is expressed on the surface of ovarian cancer cells. Nine different splice variants of MUC1 have been described, but no study has reported on the expression of MUC1 isoforms in human ovarian cancer. Our study compares patterns of expression of MUC1 splice variants of malignant and

Metallothionein expression and nuclear s
✍ Tan, Yi; Sinniah, Raja; Bay, Boon-huat; Singh, Gurmit 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB 👁 2 views

Metallothioneins (MTs) are low-molecular-weight proteins involved in metalloregulatory functions such as cell proliferation, growth, and differentiation. In recent years, MT expression has been linked with carcinogenesis, resistance to cancer therapy, and tumour progression. However, the significanc